Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Total Debt/Equity

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Total Debt/Equity(x) 0.030.04---

What is the latest Total Debt/Equity ratio of GLAND PHARMA ?

The latest Total Debt/Equity ratio of GLAND PHARMA is 0.03 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.03
Mar20240.04
Mar2023-
Mar2022-
Mar2021-

How is Total Debt/Equity of GLAND PHARMA Trending?

Years Total Debt/Equity % Change
Mar2025 0.03
-25.00
Mar2024 0.04
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of GLAND PHARMA


Compare Total Debt/Equity ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹41,322.6 Cr 3.2% 2.4% 24.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.2%

2.4%

24.7%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses